CelLBxHealth plc (AIM:CLBX)
London · Delayed Price · Currency is GBP · Price in GBX 1.286
+0.011 (0.82%)
Jul 28, 2026, 8:00 AM GMT
CelLBxHealth Balance Sheet
Financials in millions GBP. Fiscal year is January - December.
Millions GBP. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 2.88 | 7.35 | 10.43 | 16.22 | 31.9 | 31.84 |
Cash & Short-Term Investments | 2.88 | 7.35 | 10.43 | 16.22 | 31.9 | 31.84 |
Cash Growth | -60.88% | -29.51% | -35.72% | -49.15% | 0.18% | 11.25% |
Accounts Receivable | 2.17 | 1.74 | 2.09 | 1.81 | 1.8 | 1.27 |
Inventory | 1.14 | 1.3 | 1.58 | 1.68 | 2.06 | 1.75 |
Other Current Assets | - | - | 2.32 | 1.51 | 2.88 | 4.51 |
Total Current Assets | 6.18 | 10.39 | 16.41 | 21.22 | 38.63 | 39.37 |
Net Property, Plant & Equipment | 1.36 | 1.81 | 6.4 | 7.23 | 8.48 | 4.38 |
Other Intangible Assets | 0.27 | 0.39 | 2.65 | 2.74 | 2.76 | 3.57 |
Total Assets | 7.81 | 12.58 | 25.46 | 31.18 | 49.87 | 47.32 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | -1.36 | -2.34 | -2.22 | -2.75 | -3.98 | -4.39 |
Accrued Expenses | -0.21 | -0.18 | - | - | - | - |
Current Portion of Leases | -0.43 | -0.82 | -0.86 | -0.65 | -0.66 | -0.52 |
Other Current Liabilities | -0.44 | -0.43 | -0.18 | -0.54 | -0.61 | - |
Total Current Liabilities | -2.43 | -3.77 | -3.26 | -3.94 | -5.25 | -4.91 |
Long-Term Leases | -0.88 | -1 | -3.35 | -3.91 | -4.34 | -1.82 |
Other Long-Term Liabilities | -0.38 | -0.62 | -0.41 | -0.4 | -0.22 | -0.26 |
Total Long-Term Liabilities | -1.26 | -1.62 | -3.76 | -4.3 | -4.56 | -2.07 |
Total Liabilities | -3.7 | -5.39 | -7.02 | -8.24 | -9.81 | -6.99 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 32.67 | 32.67 | 32.26 | 26.06 | 26.06 | 23.51 |
Treasury Stock | - | -0.13 | -0.1 | -0.1 | -0.1 | -0.1 |
Additional Paid-in Capital | 125.71 | 127.88 | 122.12 | 121.63 | 121.24 | 102.13 |
Accumulated Other Comprehensive Income | -1.44 | -1.07 | -2.69 | -2.32 | -3.43 | -1.41 |
Retained Earnings | -152.84 | -152.16 | -133.15 | -122.33 | -103.7 | -83.81 |
Shareholders' Equity | 4.11 | 7.2 | 18.44 | 22.94 | 40.06 | 40.33 |
Total Liabilities & Equity | 0.41 | 1.81 | 11.42 | 14.7 | 30.26 | 33.35 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | -1.31 | -1.82 | -4.21 | -4.55 | -5 | -2.34 |
Net Cash (Debt) | 4.19 | 9.17 | 14.64 | 20.77 | 36.9 | 34.18 |
Net Cash Growth | -54.33% | -37.37% | -29.54% | -43.70% | 7.96% | 14.00% |
Net Cash Per Share | 0.01 | 0.03 | 0.05 | 0.08 | 0.15 | 0.15 |
Book Value | 4.11 | 7.2 | 18.44 | 22.94 | 40.06 | 40.33 |
Book Value Per Share | 0.00 | 0.02 | 0.06 | 0.09 | 0.16 | 0.18 |
Tangible Book Value | 3.84 | 6.81 | 15.79 | 20.2 | 37.3 | 36.76 |
Tangible Book Value Per Share | 0.00 | 0.02 | 0.05 | 0.08 | 0.15 | 0.16 |